Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Below averageEnvista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. We help our customers deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the human smile.
In the company’s own words · 10-K filed Feb 12, 2026 · SEC EDGAR
Business segments
Jun 2026 · $471.0MThe company’s own SEC segment disclosure.
- North America$184.7M39%
- Western Europe$133.2M28%
- High Growth Markets$128.7M27%
- Other Developed Markets$24.4M5%
Envista Holdings Corporation (NVST) reported revenue of $706M in Q1 2026 (quarter ended Apr 3, 2026), up 14% from the same quarter a year earlier. That came with a gross margin of 55% and net income of $39M (5.5% of revenue). For the full year FY2025, revenue was $2.72B (+8.3% year on year) and net income $47M. Its largest region in Jun 2026 was North America at $185M, 39% of the disclosed total, ahead of Western Europe at 28%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Medical Instruments & Supplies
Ranks #15 of 19 by Smart Score